Hygroton and Flomax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hygroton (chlorthalidone) and Flomax (tamsulosin hydrochloride). Common drug interactions include upper gastrointestinal haemorrhage among females and intraocular pressure increased among males.

The phase IV clinical study analyzes what interactions people have when they take Hygroton and Flomax. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Hygroton?

Hygroton has active ingredients of chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 1,463 Hygroton users. Check the latest studies of Hygroton.

What is Flomax?

Flomax has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. eHealthMe is studying from 52,865 Flomax users. Check the latest studies of Flomax.



On Jul, 11, 2026

27 people who take Hygroton and Flomax together, and have interactions are studied.

Hygroton and Flomax drug interactions.

What are the common drug interactions of Hygroton and Flomax, by gender? *:

female:

  1. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

male:

  1. Intraocular pressure increased
  2. Abdominal distension
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Blood sodium decreased
  5. Cardiac disorder
  6. Conjunctivitis (pink eye)
  7. Decreased interest
  8. Disability
  9. Dizziness
  10. Drug hypersensitivity

What are the common drug interactions of Hygroton and Flomax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Blood sodium decreased
  4. Conjunctivitis (pink eye)
  5. Drug hypersensitivity
  6. Immunoglobulins decreased
  7. Inappropriate antidiuretic hormone secretion
  8. Infusion related reaction
  9. Infusion site pain
  10. Injection site erythema (redness at injection site)

50-59:

  1. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)

60+:

  1. Intraocular pressure increased
  2. Drug ineffective
  3. Disease progression
  4. Fatigue (feeling of tiredness)
  5. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  6. Hepatic failure (liver failure)
  7. Hyperbilirubinaemia (excess of bilirubin in the blood)
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Impaired healing
  10. Lactic acidosis (low ph in body tissues)

What are the existing conditions these people have? *

  1. Pain: 8 people, 29.63%
  2. Gastric Disorder (disease of stomach): 6 people, 22.22%
  3. Wheezing (a high-pitched whistling sound made while you breath): 4 people, 14.81%
  4. Sleep Disorder: 4 people, 14.81%
  5. Muscle Spasms (muscle contraction): 4 people, 14.81%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.81%
  7. Prostatic Disorder: 3 people, 11.11%
  8. Primary Immunodeficiency Syndrome: 3 people, 11.11%
  9. Immunodeficiency Common Variable: 3 people, 11.11%
  10. Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Hygroton and Flomax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hygroton and Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hygroton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hygroton and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flomax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on chlorthalidone and tamsulosin hydrochloride (the active ingredients of Hygroton and Flomax, respectively), and Hygroton and Flomax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: